Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 326 - 350 of 3913 in total
Main Class Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA03
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Gb3(d18:1/20:0)
44260166 84692 1079.733169 C56H105NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA04
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Gb3(d18:1/22:0)
44260167 84694 1107.764469 C58H109NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA05
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Gb3(d18:1/24:0)
44260168 84695 1135.795769 C60H113NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA06
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Gb3(d18:1/26:0)
44260169 75188 1163.827069 C62H117NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA07
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Gb3(d18:1/24:1(15Z))
44260170 84696 1133.780119 C60H111NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA08
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Gb3(d18:1/26:1(17Z))
44260171 133816 1161.811419 C62H115NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB00
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Globoside I/Cytolipin K
GSG1154 18259
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB01
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Globoside I/Cytolipin K(d18:1/16:0)
44260172 132968 1226.749943 C60H110N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB02
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Globoside I/Cytolipin K(d18:1/18:0)
44260173 52988 1254.781243 C62H114N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB03
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Globoside I/Cytolipin K(d18:1/20:0)
44260174 1282.812543 C64H118N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB04
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Globoside I/Cytolipin K(d18:1/22:0)
44260175 1310.843843 C66H122N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB05
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Globoside I/Cytolipin K(d18:1/24:0)
44260176 1338.875143 C68H126N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB06
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Globoside I/Cytolipin K(d18:1/26:0)
44260177 1366.906443 C70H130N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB07
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Globoside I/Cytolipin K(d18:1/24:1(15Z))
44260178 84125 1336.859493 C68H124N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB08
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Globoside I/Cytolipin K(d18:1/26:1(17Z))
44260179 1364.890793 C70H128N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC00
  • Forssman antigen
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1161 18056
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC03
  • Forssman antigen(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260182 1485.891917 C72H131N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC04
  • Forssman antigen(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260183 1513.923217 C74H135N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC05
  • Forssman antigen(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260184 1541.954517 C76H139N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC06
  • Forssman antigen(d18:1/26:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260185 1569.985817 C78H143N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC07
  • Forssman antigen(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260186 1539.938867 C76H137N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC08
  • Forssman antigen(d18:1/26:1(17Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260187 1567.970167 C78H141N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD00
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Para-Forssman x3b
GSG1338

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024